UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ecosystem services assessment tools for African Biosphere Reserves: A review and user-informed classification

Ecosystem services, 2020-04, Vol.42, p.101079, Article 101079

2020

Volltextzugriff (PDF)

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

AIDS reviews, 2011-04, Vol.13 (2), p.77-108

2011

Volltextzugriff (PDF)

Formation of metamorphic biotite by decarbonation

Lithos, 1976-10, Vol.9 (4), p.309-318

De Béthune, S.

1976

Volltextzugriff (PDF)

The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool

AIDS (London), 2011-09, Vol.25 (15), p.1855-1863

2011

Volltextzugriff (PDF)

Adorno contre son temps

2019

Volltextzugriff (PDF)

Genèse d'un filon de quartz à Ottré (Massif de Stavelot, Belgique) par métasomatose de phyllades à chloritoïde

Annales de la Société géologique du Nord, 1985, Vol.105, p.121-131

1985

Volltextzugriff (PDF)

Les épidotites de Libramont

Annales de la Société géologique de Belgique, 1981-06, Vol.104

Stanislas de Béthune

1981

Volltextzugriff (PDF)

RS data fusion by local mean and variance matching algorithms: their respective efficiency in a complex urban context

IEEE/ISPRS Joint Workshop on Remote Sensing and Data Fusion over Urban Areas (Cat. No.01EX482), 2001, p.105-111

2001

Volltextzugriff (PDF)

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.718-727

2010

Volltextzugriff (PDF)

TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2314-2321

2005

Volltextzugriff (PDF)

TMC125 Displays a High Genetic Barrier to the Development of Resistance: Evidence from In Vitro Selection Experiments

Journal of Virology, 2005-10, Vol.79 (20), p.12773-12782

2005

Volltextzugriff (PDF)

TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy, 2004-12, Vol.48 (12), p.4680-4686

2004

Volltextzugriff (PDF)

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)

Antiviral research, 2010, Vol.85 (1), p.75-90

de Bethune, Marie-Pierre

2010

Volltextzugriff (PDF)

Structural and Thermodynamic Basis for the Binding of TMC114, a Next-Generation Human Immunodeficiency Virus Type 1 Protease Inhibitor

Journal of Virology, 2004-11, Vol.78 (21), p.12012-12021

2004

Volltextzugriff (PDF)

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

Antimicrobial Agents and Chemotherapy, 2008-04, Vol.52 (4), p.1302-1317

2008

Volltextzugriff (PDF)

Das christliche Gebet eines Zen-Praktizierenden

Concilium, 2024, Vol.60 (4), p.85-90

Béthune, Pierre-François de

2024

Volltextzugriff (PDF)

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

AIDS (London), 2010-02, Vol.24 (4), p.503-514

2010

Volltextzugriff (PDF)

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

The Lancet (British edition), 2007-07, Vol.370 (9581), p.49-58

2007

Volltextzugriff (PDF)

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

Journal of Virology, 2003-08, Vol.77 (15), p.8263-8271

2003

Volltextzugriff (PDF)

Resistance profile of darunavir: combined 24-week results from the POWER trials

AIDS research and human retroviruses, 2008-03, Vol.24 (3), p.379-388

2008

Volltextzugriff (PDF)

A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

Antimicrobial Agents and Chemotherapy, 1998-02, Vol.42 (2), p.269-276

1998

Volltextzugriff (PDF)

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients

AIDS (London), 2009-09, Vol.23 (14), p.1829-1840

2009

Volltextzugriff (PDF)

In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)

Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.1901-1909

2005

Volltextzugriff (PDF)

1 – 25 von 323

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(270)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(98)
Humans
(74)
Biological And Medical Sciences
(52)
Medical Sciences
(49)
Hiv-1 - Drug Effects
(41)
Infectious Diseases
(37)
Pharmacology. Drug Treatments
(36)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(35)
Antiviral Agents
(35)
Pharmacology & Pharmacy
(32)
Virology
(31)
Human Immunodeficiency Virus 1
(30)
Hiv Infections - Drug Therapy
(26)
Immunology
(24)
Aids/hiv
(23)
Physical Sciences
(22)
Chemistry
(20)
Human Viral Diseases
(20)
Microbiology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ecosystem services assessment tools for African Biosphere Reserves: A review and user-informed classification

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

Formation of metamorphic biotite by decarbonation

The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool

La valeur de l’émotion musicale

Adorno contre son temps

Genèse d'un filon de quartz à Ottré (Massif de Stavelot, Belgique) par métasomatose de phyllades à chloritoïde

Les épidotites de Libramont

RS data fusion by local mean and variance matching algorithms: their respective efficiency in a complex urban context

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates

TMC125 Displays a High Genetic Barrier to the Development of Resistance: Evidence from In Vitro Selection Experiments

TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)

Structural and Thermodynamic Basis for the Binding of TMC114, a Next-Generation Human Immunodeficiency Virus Type 1 Protease Inhibitor

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

Das christliche Gebet eines Zen-Praktizierenden

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

Resistance profile of darunavir: combined 24-week results from the POWER trials

A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients

In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)

Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 Variants

Suchergebnisse filtern